EPSTEIN ROBERT S — SEC Form 4 filings
SEC reporting owner CIK 1252004. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-05-17 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 46,473 shares, $1,768,163 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 21,473 shares @ $35.08 ($753,204) in VERACYTE, INC., filed 2025-10-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERACYTE, INC. (VCYT) | Director | 7 | — | 3 legs · 46,473 sh · $1,768,163 | 9 |
| FATE THERAPEUTICS INC (FATE) | Director | 4 | — | — | 5 |
| ILLUMINA, INC. (ILMN) | Director | 2 | — | — | 3 |
Form 4 filings — EPSTEIN ROBERT S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 5,272 @ $0 | EDGAR |
| 2026-05-22 | 4 | VERACYTE, INC. (VCYT) | Sale (S): 10,000 @ $44.01 | EDGAR |
| 2026-05-06 | 4 | FATE THERAPEUTICS INC (FATE) | Option exercise (M): 25,000 @ $1.69 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | VERACYTE, INC. (VCYT) | Option exercise (M): 10,000 @ $7.94 · Sale (S): 21,473 @ $35.08 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 9,321 @ $0 | EDGAR |
| 2025-05-30 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 3,780 @ $0 | EDGAR |
| 2025-01-08 | 4 | VERACYTE, INC. (VCYT) | Option exercise (M): 20,000 @ $8.04 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | VERACYTE, INC. (VCYT) | Option exercise (M): 15,000 @ $8.04 · Sale (S): 15,000 @ $38.32 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 11,473 @ $0 | EDGAR |
| 2024-06-11 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | ILLUMINA, INC. (ILMN) | Tax withholding (F): 612 @ $115.01 · Grant/award (A): 2,622 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1252004 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →